Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis (Q36605131)

15 August 2017

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis (English)

1 reference

15 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

David Collier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

James H. MacCabe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Cathryn Lewis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

D Cohen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

3 March 2015

1 reference

The Pharmacogenomics Journal

15 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

461-466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

4 June 2020

copyright license

start time

3 March 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/tpj.2015.5

0 references

cites work

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Imputation of TPMT defective alleles for the identification of patients with high-risk phenotypes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Clozapine: a review of clinical practice guidelines and prescribing trends

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Clozapine: balancing safety with superior antipsychotic efficacy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Genetics of antipsychotic-induced side effects and agranulocytosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Clozapine-induced agranulocytosis and its genetic determinants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

HLA-B*5701 screening for hypersensitivity to abacavir

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Haematological toxicity of drugs used in psychiatry

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Restarting clozapine after neutropenia: evaluating the possibilities and practicalities

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Treatment-resistant schizophrenia--the role of clozapine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Mechanisms of clozapine-induced agranulocytosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Agranulocytosis during treatment with chlozapine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Clozapine: a distinct, poorly understood and under-used molecule

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Medication and suicide risk in schizophrenia: a nested case-control study

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762904

Candidate Gene Analysis Identifies a Polymorphism inHLA-DQB1Associated With Clozapine-Induced Agranulocytosis

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FTPJ.2015.5

Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25732907

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25732907

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clozapine-induced leukopenia: arguments for rechallenge

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25732907

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/TPJ.2015.5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25732907%20AND%20SRC:MED&resulttype=core&format=json